Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, B. E.
Right arrow Articles by Dyck, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, B. E.
Right arrow Articles by Dyck, P. J.
NEUROLOGY 1990;40:1035
© 1990 American Academy of Neurology

Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with l-tryptophan ingestion

Benn E. Smith, MD and Peter James Dyck, MD

Peripheral Neuropathy Research Laboratory, Mayo Clinic and Mayo Foundation, Rochester, MN.

Eosinophilia, brawny induration, and tenderness of the skin and deeper tissues, and eosinophilic and lymphocytic infiltration of skin, deep fascia, and muscle characterize the acute eosinophilia-myalgia syndrome associated with ingestion of l-tryptophan. Many patients have a florid inflammatory myopathy. We evaluated 10 patients with this syndrome in whom peripheral neuropathy was a prominent or the only presenting feature. Two of these patients with severe neuromuscular disease required mechanical ventilation, and 1 died. Clinical severity appeared to be positively associated with the total dose of l-tryptophan ingested. Although the inflammation is generally thought to be more severe in skin, fascia, and muscle, inflammation, especially in the epineurium of sural nerve, was sometimes striking and often accompanied by vasculopathy and angioneogenesis. These cases draw attention to a new preventable syndrome with peripheral nerve involvement, emphasize the value of tissue biopsy for its diagnosis, and raise issues related to pathogenesis.

Address correspondence and reprint requests to Dr. Peter James Dyck, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Received March 12, 1990. Accepted for publication in final form March 26, 1990.




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
D. M. Benjamin
L-Tryptophan: A Pharmaceutical Detective Story
Journal of Pharmacy Practice, January 1, 1991; 4(2): vi - x.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.